SC News and Research

(un)Summit: A RARE Patient Advocacy

Global Genes LIVE! Get ready for an (un)Summit! Find a variety of engaging and educational online events, meet-ups, workshops and performances.  (un)Summit: September 15-25, 2020 A RARE Patient Advocacy (un)Summit. This two-week event will provide members of the rare disease community and allies with ways to connect and engage with each other through interactive activities

(un)Summit: A RARE Patient Advocacy Read More »

Emergency Care is Not Ideal for SC Patients

Study Finds Emergency Care is Not Ideal Most people with sickle cell disease (SCD) in the U.S. are happy with their PCPs, but less so with emergency care given at a hospital to manage severe pain, according to a survey of more than 400 teenage and adult patients. How a person expects to be treated

Emergency Care is Not Ideal for SC Patients Read More »

WEBINAR SERIES Sickle Cell Science: Path to Progress

WEBINAR SERIES Sickle Cell Science: Path to Progress To commemorate Sickle Cell Awareness Month 2019, this September the National Heart, Lung, and Blood Institute (NHLBI) and partner agencies and institutions will host Sickle Cell Science: Path to Progress, a four-part webinar series that will discuss genetic therapies, progress in pain management, bone marrow transplants and other therapies, and

WEBINAR SERIES Sickle Cell Science: Path to Progress Read More »

GBT Announces Updated 24-Week Efficacy Data

All Patients Enrolled in Phase 3 HOPE Study Showing Statistically Significant and Sustained Improvements in Hemoglobin with Voxelotor Global Blood Therapeutics, Inc. (GBT) today announced new results from its Phase 3 HOPE Study of voxelotor in patients ages 12 and older with sickle cell disease (SCD). The findings from 274 adolescents and adults treated with

GBT Announces Updated 24-Week Efficacy Data Read More »

Shopping Cart
Scroll to Top
Secret Link